| Trial ID: | L1930 |
| Source ID: | NCT00882882
|
| Associated Drug: |
Metformin Hcl 500 Mg Extended-Release Tablets, Geneva Ptc
|
| Title: |
To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fasting Conditions
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type II Diabetes
|
| Interventions: |
DRUG: Metformin HCL 500 mg Extended-Release Tablets, Geneva PTC|DRUG: Metformin HCL 500 mg Extended-Release Tablets, Geneva PTC|DRUG: GLUCOPHAGE XR 500 mg ER Tablets Bristol-Myers Squibb|DRUG: GLUCOPHAGE XR 500 mg ER Tablets Bristol-Myers Squibb
|
| Outcome Measures: |
Primary: Bioequivalence based on AUC and Cmax, 23 days |
|
| Sponsor/Collaborators: |
Sponsor: Sandoz
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2001-06
|
| Completion Date: |
2001-06
|
| Results First Posted: |
|
| Last Update Posted: |
2017-03-29
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00882882
|
